Hints and tips:
Related Special Reports
...The other advantage local companies have on foreign brands is domestic marketing teams and close access to factories, said Huang....
...Merck’s research chief has called on the UK government to make the country more welcoming to pharma companies, ahead of the US-based drugmaker breaking ground on a £1bn research centre in London next week...
...A trio of academics — Huang Gow-Cheng, Kartono Liano and Pan Ming-Shiun — found no improvement in operating performance relative to non-splitting companies in the four years post-split....
...The Cypriot government allowed stocks to be used to treat cats suffering with another coronavirus in the Mediterranean country, though the company said it was not approved for veterinary treatment and no...
...But, of course, there’s a reason why it’s widely called Shitibank; the sprawling, gormless Citi has for a v v v very long time proven adept at blithely ambling onto various rakes around the world....
...Merck’s drug raised fresh hopes and sent shares in the company rallying late last year after early data from a late-stage trial suggested that it cut in half the risk of death and hospitalisation....
...A version of this article was first published by Nikkei Asia on January 26. ©2024 Nikkei Inc. All rights reserved....
...The new rules give the federal government the power to negotiate lower prices for some of the most expensive prescription drugs produced by Pfizer, Merck and other pharma companies purchased by Medicare,...
...Merck’s lawsuit is the first by a major drug company, but analysts predict others are likely to follow its lead and sue the government ahead of the full implementation of the drug price negotiation elements...
...Yet Merck recorded sales worth more than $6bn between 2021 and 2022, and the figure does not include sales in poorer markets where licensed companies make generic versions of the drug....
...All told, Ayotte and Huang calculate that the loan charged an effective rate of 545 per cent....
...Yet the company’s monoclonal antibody treatment for inflammatory bowel disease has yet to be fully approved....
...Its companies have combined annual revenues of $75bn and 115,000 employees....
...Merck said the deal would strengthen the company’s position in the fast-growing field of immunology, where there is significant unmet patient need....
...A version of this article was first published by Nikkei Asia on August 21. ©2023 Nikkei Inc. All rights reserved....
...the crisp company....
...“We are encouraged by these findings from Panoramic,” said Merck, which is known as MSD outside North America....
...Implementing the proposals could undermine the company’s core business model, said Merck in response to a proposal made by The Capuchin Franciscan Province of St. Joseph....
...But such a move would have an effect on the company over time, she added....
...Merck was in talks last summer to acquire Seagen for about $200 a share, or $40bn. But negotiations ended after the two failed to agree on price....
...Dean Li, president of Merck Research Laboratories, said the positive trial findings represented an important milestone in the company’s collaboration with Moderna....
...Qian Huang, founder of Passive Edge, said his start-up had a similar edge, with pricing at about half that of British and German competitors....
...Merck had been in talks to acquire Seagen last summer, offering about $200 a share, according to people familiar with the matter....
...Merck’s drug, which is branded Lagevrio, raised hopes and sent shares in the company rallying last year after early data from a late-stage trial suggested it cut in half the risk of death and hospitalisation...
...Campaigners are supported by more than 400 senior pharma and biotech executives at companies, including Pfizer and Merck, who have spoken out against a preliminary injunction against abortion pill mifepristone...
International Edition